Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant CD74 (Milatuzumab Biosimilar) antibody

The Human Monoclonal anti-CD74 (Milatuzumab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect CD74 (Milatuzumab Biosimilar) in samples from Human.
Catalog No. ABIN7581310

Quick Overview for Recombinant CD74 (Milatuzumab Biosimilar) antibody (ABIN7581310)

Target

CD74 (Milatuzumab Biosimilar)

Antibody Type

Recombinant Antibody

Reactivity

Human

Host

  • 3
Human

Clonality

  • 2
  • 1
Monoclonal

Conjugate

  • 2
  • 1
This CD74 (Milatuzumab Biosimilar) antibody is un-conjugated

Application

ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)
  • Expression System

    CHO Cells

    Purpose

    Anti-CD74 Reference Antibody (milatuzumab)

    Sequence

    QVQLQQSGSE LKKPGASVKV SCKASGYTFT NYGVNWIKQA PGQGLQWMGW INPNTGEPTF DDDFKGRFAF SLDTSVSTAY LQISSLKADD TAVYFCSRSR GKNEAWFAYW GQGTLVTVSS ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKRVEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSREE MTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPGK ,DIQLTQSPLS LPVTLGQPAS ISCRSSQSLV HRNGNTYLHW FQQRPGQSPR LLIYTVSNRF SGVPDRFSGS GSGTDFTLKI SRVEAEDVGV YFCSQSSHVP PTFGAGTRLE IKRTVAAPSV FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC

    Characteristics

    Anti-CD74 Reference Antibody (milatuzumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

    Purity

    >95 %

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Therapeutic Agents by Target and Mechanism: CD74 inhibitors

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Concentration

    1 mg/mL

    Buffer

    25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

    Storage

    4 °C,-80 °C

    Storage Comment

    +4°C,-80°C
  • Target

    CD74 (Milatuzumab Biosimilar)

    Target Type

    Biosimilar

    Molecular Weight

    145.5 kDa

    UniProt

    P04233
You are here:
Chat with us!